Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?

To: Nanny who wrote (335)	1/3/1998 2:51:00 PM
From: EmuGreg	Respond to of 4140

Just thinking.... One of the keys to SNRS getting to the valuation(s) that we all think it should rise to is getting institutional attention (I know, this is obvious). In the past I've e-mailed parts of newsreleases on SNRS to fund managers that deal with development stage medical companies. Many of these folks like to receive information like this. The responses I've gotten in the past is that they would wait until they saw indications of Dr. and patient acceptance. They are just as interested in the market response to the technology as the technology itself. Now that we are past the holidays and into a new year, hopefully we will get some good newsreleases. This may sound too simple to be of any use, but perhaps everyone could have a couple of institutional types to forward these onto, particularly if we get some that indicate Dr. support, as soon as a release occurs. One fund buying SNRS could make a big difference. I realize that most funds don't buy companies at this stage, but there are some. Forwarding information on to newsletters is also a fertile area. Wishing everyone a prosperous 1998... Greg